Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

74.91 -0.20 (-0.27%)
Streaming Delayed Price Updated: 1:07 PM EDT, Aug 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 102,836
Open 75.48
Bid (Size) 74.69 (200)
Ask (Size) 75.14 (200)
Prev. Close 75.11
Today's Range 74.00 - 75.75
52wk Range 70.15 - 99.50
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 25.9... 
Via StockStory

Performance

YTD
-4.5%
-4.5%
1 Month
-7.6%
-7.6%
3 Month
-7.4%
-7.4%
6 Month
-1.8%
-1.8%
1 Year
-15.2%
-15.2%

More News

Read More
News headline image
ANI Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
ANI Pharmaceuticals (NASDAQ:ANIP) Tumbles on Weak Guidance Despite Q2 EPS Beat ↗
Via Chartmill
ANI Pharmaceuticals (NASDAQ:ANIP) Crushes Q1 Estimates, Raises Full-Year Guidance ↗
Via Chartmill
News headline image
ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance
Via StockStory
Topics Earnings
News headline image
ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Question
Via StockStory
News headline image
Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Via StockStory
News headline image
2 Reasons to Watch ANIP and 1 to Stay Cautious
Via StockStory
News headline image
2 Small-Cap Stocks Worth Investigating and 1 We Brush Off
Via StockStory
News headline image
ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run ↗
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
2 Value Stocks for Long-Term Investors and 1 We Avoid
Via StockStory
News headline image
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 of Wall Street’s Favorite Stocks to Target This Week
Via StockStory
News headline image
2 Cash-Producing Stocks to Research Further and 1 Facing Challenges
Via StockStory
News headline image
Ani (ANIP) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
2 Growth Stocks with Explosive Upside and 1 We Avoid
Via StockStory
News headline image
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds
Via StockStory
News headline image
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million ↗
Via The Motley Fool
News headline image
ANI Pharmaceuticals Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings Intellectual Property

Frequently Asked Questions

Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
The current price of ANI Pharmaceuticals, Inc. - Common Stock is 74.91
When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 08/13/26 01:07 PM ET
What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 1.83B
How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS